Milestone Scientific (MLSS)
(Delayed Data from AMEX)
$0.56 USD
0.00 (0.34%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $0.56 0.00 (0.18%) 7:30 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MLSS 0.56 0.00(0.34%)
Will MLSS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MLSS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MLSS
Milestone Scientific, Inc. (MLSS) Reports Q3 Loss, Lags Revenue Estimates
MLSS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MLSS
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida
Milestone Scientific commences sales of CompuFlo Epidural Disposables in Florida
Milestone Scientific: A Strong Buy on Robust Financials and Market Expansion Potential
MLSS Stock Earnings: Milestone Scientific Misses Revenue for Q4 2023
Milestone Scientific GAAP EPS of -$0.10, revenue of $9.83M